Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy

Humoral vaccine responses are known to be suboptimal in patients receiving B-cell targeted therapy, and little is known about vaccine induced T-cell immunity in these patients. In this study, we characterized humoral and cellular antigen-specific anti-SARS-CoV2 responses following COVID-19 vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Marty, Paige K., Van Keulen, Virginia P., Erskine, Courtney L., Shah, Maleeha, Hummel, Amber, Stachowitz, Michael, Fatis, Samantha, Granger, Dane, Block, Matthew S., Duarte-García, Alí, Warrington, Kenneth J., Theel, Elitza S., Zhou, Xian, Zeng, Hu, Specks, Ulrich, Escalante, Patricio, Peikert, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831839/
https://www.ncbi.nlm.nih.gov/pubmed/35154159
http://dx.doi.org/10.3389/fimmu.2022.834981

Ejemplares similares

Ejemplares similares